Navigation Links
Albright Technologies, the Leader in Medical Silicone Molding, Appoints New President

Leominster, MA (PRWEB) March 28, 2013

Albright Technologies today announced that David Comeau has stepped down as the company’s President, effective January 1, 2013. Comeau will continue to contribute on the technical side as part owner while working on a start-up project. Bob Waitt, formerly the VP of Business Development, will assume the role of President and CEO.

Like many small companies, Albright was started in a garage with only a few employees. Over the last 18 years Albright has grown into a successful company with 15 employees, a clean room, machine shop and molding room. The company began with the original focus of medical plastic prototyping. However, the world of medical device manufacturing continued to evolve with medical researchers looking for products to better suit the human body. So in 2005, Albright made a strategic decision to transition from plastic to silicone, a more bio-inert material.

Bob Waitt has been with the company for 12 years and has served as the VP of Business Development since 2008. He started with the company in 2000, then received a Bachelor of Science in Electrical Engineering from Boston University in 2006 and has since been concentrating on helping Albright expand, evolve and become a leader in the silicone molding industry.

“Bob Waitt has been my partner for the last 5 years and has had an integral role in growing the company into what it is today; I am happy now to be turning the company over to him,” said Comeau. “Bob started with the company in 2000, and has had many positions over his years at Albright allowing him to learn all aspects of the company. I have great confidence that he will continue to move Albright forward and keep it growing to its full potential.”

Everyone at Albright Technologies expresses their sincere appreciation to Comeau for his service and dedication.

About Albright Technologies:

Founded in 1995 and headquartered in Leominster, MA, USA, Albright Technologies specializes in manufacturing prototype and low volume production silicone components for Medical, Pharmaceutical, Military and Consumer Goods applications. Albright Technologies has extensive silicone molding experience and can provide silicone material selection, prototyping and design for manufacturability and scalable molding methods. Albright Technologies has created a free silicone design manual that has been downloaded over 10,000 times. For more information about Albright Technologies, contact Bob Waitt at 978-466-5870 or info(at)albright1(dot)com. To receive an online quote, request samples or download the newly revised Silicone Molding Design Manual, visit

Albright Technologies
25 Litchfield Street
Leominster, MA 01453
P 978-466-5870
F 978-466-5901

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Research and Markets - Drug Delivery in Cancer - Technologies, Markets and Companies - 2013 Report
2. Ultimate Aquatics, announces the acquisition of SUP Products, the industry leader in U.S. Made Private Label Hybrid Molded Composite (HMC) Stand Up Paddle Boards (SUP) & Accessories.
3. Michigan hospitals national leaders in preventing common and costly urinary tract infections
4. Registered Nurses Association gives awards to 2 St. Michaels nursing leaders
5. Geiger Gibson Program recognizes 8 emerging leaders at annual symposium
6. Townsend Security Releases Short, Easy to Understand Data Privacy Videos for Business Leaders
7. AIBS names emerging public policy leaders
8. Best Injury Lawyers? Time Magazine Includes Among Nations Legal Leaders
9. eHealth Thought Leadership Forum Accepting New Council Members
10. World Leader In Manufacturing Of Cleaning Solutions; Midbrook Medical, Announces The Launch Of UV Flash, 60 Second Infection Prevention Station Designed To Combat HAI's
11. Sequestration is not a smart strategy for reducing the deficit, say small business leaders
Post Your Comments:
(Date:11/25/2015)... ... , ... For the first time, Vitalalert is donating half of its earnings ... partnership between the two groups began in 2014 with Vitalalert pledging a portion of ... was founded in 1954 and is an international Christian-based health organization whose mission is ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... , ... November 25, 2015 , ... The McHenry County ... recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. ... Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... ser potential att använda SyMRI för att ... för patienter med multipel skleros (MS) eller ... SyntheticMR AB för att kunna använda SyMRI ... Med SyMRI kan man generera flera konstrastbilder ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: